Inductive Bio

Inductive Bio is a technology company that leverages machine learning (ML) to dramatically accelerate compound optimization in the drug discovery process. Their platform utilizes a proprietary ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) dataset combined with cutting-edge ML models to help scientists optimize compounds into leads and development candidates faster and with a better balance of ADMET properties. They believe that by democratizing access to these powerful tools, they can accelerate drug discovery across the entire industry.

Inductive Bio was co-founded by industry veterans Josh Haimson and Ben Birnbaum, who have extensive experience in building innovative ML products and bringing drugs to market. Their team consists of experts in machine learning, medicinal chemistry, synthetic chemistry, and DMPK, all working together to solve the complex challenges of compound optimization. Backed by leading venture capital firms like a16z, Lux Capital, Character, and Bessemer Venture Partners, Inductive Bio is poised to become a major force in the field of drug discovery.

Inductive Bio's website does not mention the company's policy on job flexibility. NONE

Inductive Bio is a technology company that uses machine learning to accelerate the compound optimization process for small-molecule drug discovery. Their mission is to democratize access to state-of-the-art computational tools for the entire industry, speeding up the development of new therapeutics by making the optimization of compounds faster and more efficient. They believe that AI can significantly reduce the time and cost associated with drug discovery, ultimately leading to safer and more effective therapies for patients.

Inductive Bio fosters a collaborative and interdisciplinary culture, emphasizing teamwork and the integration of expertise from various fields like machine learning, medicinal chemistry, and synthetic chemistry. They believe in a data-driven approach to drug discovery, making state-of-the-art computational tools accessible to the entire team, and prioritizing rigorous benchmarking and realistic evaluation methods. This culture encourages innovation, continuous learning, and a shared passion for translating scientific breakthroughs into real-world impact on complex drug programs.

Inductive Bio does not explicitly address diversity, equity, and inclusion on their website.